GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » DuChemBio Co Ltd (XKRX:176750) » Definitions » Return-on-Tangible-Asset

DuChemBio Co (XKRX:176750) Return-on-Tangible-Asset : 12.28% (As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is DuChemBio Co Return-on-Tangible-Asset?

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. DuChemBio Co's annualized Net Income for the quarter that ended in Dec. 2023 was ₩4,001 Mil. DuChemBio Co's average total tangible assets for the quarter that ended in Dec. 2023 was ₩32,584 Mil. Therefore, DuChemBio Co's annualized Return-on-Tangible-Asset for the quarter that ended in Dec. 2023 was 12.28%.

The historical rank and industry rank for DuChemBio Co's Return-on-Tangible-Asset or its related term are showing as below:

XKRX:176750' s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -37.57   Med: -6.69   Max: 12.28
Current: 12.28

During the past 8 years, DuChemBio Co's highest Return-on-Tangible-Asset was 12.28%. The lowest was -37.57%. And the median was -6.69%.

XKRX:176750's Return-on-Tangible-Asset is ranked better than
85.77% of 1082 companies
in the Drug Manufacturers industry
Industry Median: 1.84 vs XKRX:176750: 12.28

DuChemBio Co Return-on-Tangible-Asset Historical Data

The historical data trend for DuChemBio Co's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DuChemBio Co Return-on-Tangible-Asset Chart

DuChemBio Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Return-on-Tangible-Asset
Get a 7-Day Free Trial -37.57 -25.59 4.63 -7.02 12.28

DuChemBio Co Semi-Annual Data
Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Return-on-Tangible-Asset Get a 7-Day Free Trial -37.57 -25.59 4.63 -7.02 12.28

Competitive Comparison of DuChemBio Co's Return-on-Tangible-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, DuChemBio Co's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DuChemBio Co's Return-on-Tangible-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, DuChemBio Co's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where DuChemBio Co's Return-on-Tangible-Asset falls into.



DuChemBio Co Return-on-Tangible-Asset Calculation

DuChemBio Co's annualized Return-on-Tangible-Asset for the fiscal year that ended in Dec. 2023 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=4000.507/( (33280.107+31888.003)/ 2 )
=4000.507/32584.055
=12.28 %

DuChemBio Co's annualized Return-on-Tangible-Asset for the quarter that ended in Dec. 2023 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Dec. 2023 )  (Q: Dec. 2022 )(Q: Dec. 2023 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Dec. 2023 )  (Q: Dec. 2022 )(Q: Dec. 2023 )
=4000.507/( (33280.107+31888.003)/ 2 )
=4000.507/32584.055
=12.28 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is one times the annual (Dec. 2023) net income data.


DuChemBio Co  (XKRX:176750) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


DuChemBio Co Return-on-Tangible-Asset Related Terms

Thank you for viewing the detailed overview of DuChemBio Co's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


DuChemBio Co (XKRX:176750) Business Description

Traded in Other Exchanges
N/A
Address
Daegu 47, Jinyang Building, 4th floor, Chungjeong-ro 2, Gyeonggi, Seoul, KOR, 190-3
DuChemBio Co Ltd is engaged in manufacturing and sale of radiopharmaceuticals and radioactive medicines. It also imports and sells medical equipment related to nuclear medicines.

DuChemBio Co (XKRX:176750) Headlines

No Headlines